Gene Could Be New Tool to Help Predict Graves' Disease Relapse | oneGRAVESvoice

welcome to oneGRAVESvoice

- a positively charged Graves' disease and thyroid eye disease community.
  • join today!

Gene Could Be New Tool to Help Predict Graves’ Disease Relapse

Patients with Graves’ disease who carry a specific gene show a more than seven-times increased risk of relapse after treatment, suggesting a potentially reliable and important biomarker in management of the disease.

There is a high risk of relapse in Graves’ disease, but there are currently no biomarkers proven to be predictors of relapse; the latter could be essential in disease management decision-making, a coauthor of the research explained.

“The risk of relapse in Graves’ disease is quite high — around 40% to 50% in Europe, and 70% to 80% in the United States,” said Masanobu Yamada, MD, PhD, of the Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan, in a press statement by Thyroid.

“Our finding may give us a tool to find at-risk patients at an earlier stage and more effectively tailor their treatment options,” said Dr Yamada.

Gene Could Be New Tool To Help Predict Graves’ Disease Relapse
Font Resize

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.